Radiopharmaceutical agents for myocardial perfusion imaging

Circulation

Volumn 118, Issue 16, 2008, Pages 1668-1674

  Baggish, Aaron L ^a   Boucher, Charles A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Isotopes; Myocardial ischemia; Nuclear medicine; Radioisotopes; Radiopharmaceuticals

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TETROFOSMIN TC 99M; THALLIUM CHLORIDE TL 201;

CLINICAL PRACTICE; COMPUTER PROGRAM; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG MECHANISM; HEART MUSCLE PERFUSION; HUMAN; PATIENT SAFETY; PHYSIOLOGY; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; HEART DISEASE; METHODOLOGY; SCINTISCANNING;

CORONARY CIRCULATION; HEART DISEASES; HUMANS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 55949116109     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.778860     Document Type: Review

References (50)

1. Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW, Pohost GM. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol. 1983;1:994-1001.
2. Boucher CA, Brewster DC, Darling RC, Okada RD, Strauss HW, Pohost GM. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med. 1985;312:389-394.
3. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol. 1998;32:57-62.
4. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535-543.
5. Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ, Beller GA. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation. 1983; 68:321-336.
6. Higley B, Smith J=W, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV, Graham D, Hinge D, Davidson J, Lahiri A. Technetium-99m-1,2-bis[bis(2- ethoxyethyl) phosphino]ethane: human biodistribution. dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30-38.
7. 99mTc]HEXAMIBI Phase I and II Studies. Technetium99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med. 1989;30:301-311.
8. Gibbons RJ. Myocardial perfusion imaging. Heart. 2000;83:355-360.
9. Henzlova MJ, Cerqueira MD, Mahmarian JJ, Yao SS. Stress protocols and tracers. J Nucl Cardiol. 2006;13:e80-e90.
10. Husain SS. Myocardial perfusion imaging protocols: is there an ideal protocol? J Nucl Med Technol. 2007;35:3-9.
11. Brindis RG, Douglas PS, Hendel RC, Peterson ED, Wolk MJ, Allen JM, Patel MR, Raskin IE, Hendel RC, Bateman TM, Cerqueira MD, Gibbons RJ, Gillam LD, Gillespie JA, Hendel RC, Iskandrian AE, Jerome SD, Krumholz HM, Messer JV, Spertus JA, Stowers SA. ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol. 2005;46:1587-1605.
12. Ward RP, Al-Mallah MH, Grossman GB, Hansen CL, Hendel RC, Kerwin TC, McCallister BD Jr, Mehta R, Polk DM, Tilkemeier PL, Vashist A, Williams KA, Wolinsky DG, Ficaro EP. American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). J Nucl Cardiol. 2007;14:e26-e38.
13. Kaul S, Boucher CA, Newell JB, Chesler DA, Greenberg JM, Okada RD, Strauss HW, Dinsmore RE, Pohost GM. Determination of the quantitative thallium imaging variables that optimize detection of coronary artery disease. J Am Coll Cardiol. 1986;7:527-537.
14. Steinberg EP, Klag MJ, Bakal CW, Strauss HW, Boucher CA, Guiney TE. Exercise thallium scans: patterns of use and impact on management of patients with known or suspected coronary artery disease. Am J Cardiol. 1987;59:50-55.
15. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, Guiney TE, Boucher CA. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med. 1989;110:859-866.
16. Okada RD, Leppo JA, Strauss HW, Boucher CA, Pohost GM. Mechanisms and time course for the disappearance of thallium-201 defects at rest in dogs: relation of time to peak activity to myocardial blood flow. Am J Cardiol. 1982;49:699-706.
17. Taillefer R. Radiopharmaceuticals. In: DePuey EG, Berman DS, Garcia EV, eds. Cardiac SPECT Imaging. 2nd ed. New York, NY: Raven Press; 2001:118-119.
18. Jain D. Technetium-99m labeled myocardial perfusion imaging agents. Semin Nucl Med. 1999;29:221-236.
19. Thallium-201 prescribing information [package insert]. Available at: http://www.imaging.mallinckrodt.com/_Attachments/PackageInserts/ Thallous%20Chloride%20Injection.pdf. Accessed March 25, 2008.
20. Sestamibi-Tc99m prescribing information [package insert]. Available at: http://www.cardiolite.com/pdfs/cardiolite.pdf. Accessed March 25, 2008.
21. Tetrofosmin-Tc99m prescribing information [package insert]. Available at: http://www.imaging.mallinckrodt.com/_Attachments/PackageInserts/ Myoview%202p%208-04.pdf. Accessed March 25, 2008.
22. Wei K, Le E, Bin JP, Coggins M, Jayawera AR, Kaul S. Mechanism of reversible (99m)Tc-sestamibi perfusion defects during pharmacologically induced vasodilatation. Am J Physiol Heart Circ Physiol. 2001;280: H1896-H1904.
23. Rothendler JA, Okada RD, Wilson RA, Brown KA, Boucher CA, Strauss HW, Pohost GM. Effect of a delay in commencing imaging on the ability to detect transient thallium defects. J Nucl Med. 1985;26:880-883.
24. Liu P, Kiess MC, Okada RD, Block PC, Strauss HW, Pohost GM, Boucher CA. The persistent defect on exercise thallium imaging and its fate after myocardial revascularization: does it represent scar or ischemia? Am Heart J. 1985;110:996-1001.
25. Okada RD, Boucher CA. Differentiation of viable and nonviable myocardium after acute reperfusion using serial thallium-201 imaging. Am Heart J. 1987;113:241-250.
26. Mujtaba B, Adenaike M, Yaganti V, Mujtaba N, Jain D. Anaphylactic reaction to Tc-99m sestamibi (Cardiolite) during pharmacologic myocardial perfusion imaging. J Nucl Cardiol. 2007;14:256-258.
27. Coffin D. AECL provides status report on NRU reactor [press release]. Available at: http://www.aecl.ca/NewsRoom/News/Press-2007/071204.htm. Accessed December 4.
28. Pitman AG, Kalff V, Van Every B, Risa B, Barnden LR, Kelly MJ. Contributions of subdiaphragmatic activity, attenuation, and diaphragmatic motion to inferior wall artifact in attenuation-corrected Tc-99m myocardial perfusion SPECT. J Nucl Cardiol. 2005;12:401-409.
29. Utsunomiya D, Tomiguchi S, Shiraishi S, Yamada K, Honda T, Kawanaka K, Kojima A, Awai K, Yamashita Y. Initial experience with X-ray CT based attenuation correction in myocardial perfusion SPECT imaging using a combined SPECT/CT system. Ann Nucl Med. 2005;19: 485-489.
30. Takahashi Y, Murase K, Mochizuki T, Higashino H, Sugawara Y, Kinda A. Segmented attenuation correction for myocardial SPECT. Ann Nucl Med. 2004;18:137-143.
31. Masood Y, Liu YH, Depuey G, Taillefer R, Araujo LI, Allen S, Delbeke D, Anstett F, Peretz A, Zito MJ, Tsatkin V, Wackers FJ. Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation. J Nucl Cardiol. 2005;12:676-686.
32. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation. 1995;92:334-341.
33. Mahmarian JJ, Boyce TM, Goldberg RK, Cocanougher MK, Roberts R, Verani MS. Quantitative exercise thallium-201 single photon emission computed tomography, for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol. 1990;15:318-329.
34. Funahashi M, Shimonagata T, Mihara K, Kashiyama K, Shimizu R, Machida S, Izumi K, Kusuoka H, Nishimura T, Hoki N, Kawamoto S. Application of pixel truncation to reduce intensity artifacts in myocardial SPECT imaging with Tc-99m tetrofosmin. J Nucl Cardiol. 2002;9: 622-631.
35. Goetze S, Wahl RL. Prevalence of misregistration between SPECT and CT for attenuation-corrected myocardial perfusion SPECT. J Nucl Cardiol. 2007;14:200-206.
36. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, Maddahi J, Germano G. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol. 1993;22:1455-1464.
37. Heo J, Wolmer I, Kegel J, Iskandrian AS. Sequential dual-isotope SPECT imaging with thallium-201 and technetium-99m-sestamibi. J Nucl Med. 1994;35:549-553.
38. Kiat H, Germano G, Friedman J, Van Train K, Silagan G, Wang FP, Maddahi J, Berman D. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT. J Nucl Med. 1994;35:542-548.
39. Acampa W, Cuocolo A, Sullo P, Varrone A, Nicolai E, Pace L, Petretta M, Salvatore M. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol. 1998;5:265-274.
40. Duncan BH, Ahlberg AW, Levine MG, McGill CC, Mann A, White MP, Mather JF, Waters DD, Heller GV. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability. Am J Cardiol. 2000;85:680-684.
41. Fleischmann S, Koepfli P, Namdar M, Wyss CA, Jenni R, Kaufmann PA. Gated (99m)Tc-tetrofosmin SPECT for discriminating infarct from artifact in fixed myocardial perfusion defects. J Nucl Med. 2004;45: 754-759.
42. Smanio PE, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol. 1997;30:1687-1692.
43. Nichols K, Dorbala S, DePuey EG, Yao SS, Sharma A, Rozanski A. Influence of arrhythmias on gated SPECT myocardial perfusion and function quantification. J Nucl Med. 1999;40:924-934.
44. Iskandrian AS, Heo J, Nguyen T, Mercuro J. Myocardial imaging with Tc-99m teboroxime: technique and initial results. Am Heart J. 1991;121: 889-894.
45. Stewart RE, Schwaiger M, Molina E, Popma J, Gacioch GM, Kalus M, Squicciarini S, al-Aouar ZR, Schork A, Kuhl DE. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol. 1991;67: 1303-1310.
46. Yoshinaga K, Chow BJ, Williams K, Chen L, deKemp RA, Garrard L, Lok-Tin Szeto A, Aung M, Davies RA, Ruddy TD, Beanlands RS. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006; 48:1029-1039.
47. Kawai Y, Tsukamoto E, Nozaki Y, Monta K, Sakurai M, Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol. 2001; 38:1888-1894.
48. Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram MY, Goodbody AE, Babich JW, Udelson JE. Metabolic imaging with betamethyl-p-[(123)I]-iodophenyl- pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation. 2005;112:2169-2174.
49. Spyrou N, Rosen SD, Fath-Ordoubadi F, Jagathesan R, Foale R, Kooner JS, Camici PG. Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. J Am Coll Cardiol. 2002;40:1216-1224.
50. Allman KC, Wieland DM, Muzik O, Degrade TR, Wolfe ER Jr, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol. 1993; 22:368-375.